Polymyxin B Sulfate and Trimethoprim (Bausch & Lomb Incorporated)
Welcome to the PulseAid listing for the Polymyxin B Sulfate and Trimethoprim drug offered from Bausch & Lomb Incorporated. This Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient],Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Bausch & Lomb Incorporated |
NON-PROPRIETARY NAME: | Polymyxin B Sulfate and Trimethoprim Sulfate |
SUBSTANCE NAME: | POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient],Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SOLUTION/ DROPS |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 1997-02-14 |
END MARKETING DATE: | 0000-00-00 |
Polymyxin B Sulfate and Trimethoprim HUMAN PRESCRIPTION DRUG Details:
Item Description | Polymyxin B Sulfate and Trimethoprim from Bausch & Lomb Incorporated |
LABELER NAME: | Bausch & Lomb Incorporated |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10000; 1([USP’U]/mL; mg/mL) |
START MARKETING DATE: | 1997-02-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 24208-315_936bf9de-2c00-4340-8b42-f9c7d75959d2 |
PRODUCT NDC: | 24208-315 |
APPLICATION NUMBER: | ANDA064120 |
Other POLYMYXIN B SULFATE; TRIMETHOPRIM SULFATE Pharmaceutical Manufacturers / Labelers: